DexCom Inc
(NAS:DXCM)
$
116.06
3.05 (2.7%)
Market Cap: 46.16 Bil
Enterprise Value: 44.66 Bil
PE Ratio: 74.88
PB Ratio: 20.47
GF Score: 88/100 - Q1 2024 Dexcom Inc Earnings Call TranscriptApr 25, 2024$138.01 (+0.10%)Earnings
- Q4 2023 Dexcom Inc Earnings Call TranscriptFeb 08, 2024$127.05 (+0.35%)Earnings
- Dexcom Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Dexcom Inc at Piper Sandler Healthcare Conference TranscriptNov 29, 2023
- Q3 2023 Dexcom Inc Earnings Call TranscriptOct 26, 2023$81.09 (-3.86%)Earnings
- Dexcom Inc at Robert W Baird Global Healthcare Conference TranscriptSep 13, 2023
- Dexcom Inc at Wells Fargo Healthcare Conference TranscriptSep 06, 2023
- Q2 2023 Dexcom Inc Earnings Call TranscriptJul 27, 2023$129.36 (-1.02%)Earnings
- Dexcom Inc Investor Day TranscriptJun 23, 2023
- Dexcom Inc at William Blair Growth Stock Conference TranscriptJun 07, 2023
- Q1 2023 Dexcom Inc Earnings Call TranscriptApr 27, 2023$123.58 (-1.08%)Earnings
- Dexcom Inc at Raymond James Institutional Investors Conference TranscriptMar 07, 2023
- Dexcom Inc at Citi Healthcare & Medtech Conference TranscriptMar 01, 2023
- Q4 2022 Dexcom Inc Earnings Call TranscriptFeb 09, 2023$107.24 (-2.37%)Earnings
- Dexcom Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Dexcom Inc at Piper Sandler Healthcare Conference TranscriptNov 30, 2022
- Q3 2022 Dexcom Inc Earnings Call TranscriptOct 27, 2022$101.25 (-1.33%)Earnings
- Dexcom Inc at Robert W Baird Global Healthcare Conference TranscriptSep 14, 2022
- Dexcom Inc at Wells Fargo Healthcare Conference TranscriptSep 07, 2022
- Dexcom Inc at Canaccord Genuity Growth Conference TranscriptAug 10, 2022
- Q2 2022 Dexcom Inc Earnings Call TranscriptJul 28, 2022$86.99 (+1.39%)Earnings
- Dexcom Inc at William Blair Growth Stock Conference TranscriptJun 08, 2022
- Dexcom Inc at Piper Sandler Ophthalmology and Diabetes Symposium (Virtual) TranscriptMay 25, 2022
- Dexcom Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Q1 2022 Dexcom Inc Earnings Call TranscriptApr 28, 2022$103.31 (+0.05%)Earnings
- Dexcom Inc at Citi Healthcare Conference (Virtual) TranscriptFeb 23, 2022
- Dexcom Inc at SVB Leerink Global Healthcare (Virtual) TranscriptFeb 16, 2022
- Q4 2021 Dexcom Inc Earnings Call TranscriptFeb 10, 2022$110.57 (-1.25%)Earnings
- Dexcom Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Dexcom Inc at Piper Sandler Healthcare Conference (Virtual) TranscriptDec 01, 2021
- Q3 2021 Dexcom Inc Earnings Call TranscriptOct 28, 2021$142.58 (+2.11%)Earnings
- Dexcom Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Dexcom Inc at Wells Fargo Virtual Healthcare Conference TranscriptSep 10, 2021
- Q2 2021 Dexcom Inc Earnings Call TranscriptJul 29, 2021$114.01 (-0.84%)Earnings
- Dexcom Inc at William Blair Growth Stock Conference (Virtual) TranscriptJun 01, 2021
- Q1 2021 Dexcom Inc Earnings Call TranscriptApr 29, 2021$105.43 (-0.96%)Earnings
- Dexcom Inc at Raymond James Institutional Investors Conference (Virtual) TranscriptMar 01, 2021
- Dexcom Inc at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 25, 2021
- Dexcom Inc at Citi Healthcare Services, Medtech, Tools, & HCIT Virtual Conference TranscriptFeb 24, 2021
- Q4 2020 DexCom Inc Earnings Call TranscriptFeb 11, 2021$102.55 (+2.69%)Earnings
- DexCom Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- DexCom Inc Investor Day TranscriptDec 09, 2020
- DexCom Inc at Piper Sandler Healthcare Conference (Virtual) TranscriptDec 01, 2020
- DexCom Inc at Stifel Virtual Healthcare Conference TranscriptNov 16, 2020
- Q3 2020 DexCom Inc Earnings Call TranscriptOct 27, 2020$95.16 (-8.94%)Earnings
- DexCom Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2020
- DexCom Inc at Wells Fargo Virtual Healthcare Conference TranscriptSep 10, 2020
- DexCom Inc at Robert W Baird Global Healthcare Conference TranscriptSep 09, 2020
- DexCom Inc at Canaccord Genuity Growth Conference (Virtual) TranscriptAug 12, 2020
- Q2 2020 DexCom Inc Earnings Call TranscriptJul 28, 2020$104.45 (-1.33%)Earnings
- DexCom Inc at William Blair Growth Stock Conference TranscriptJun 09, 2020
- Q1 2020 DexCom Inc Earnings Call TranscriptApr 28, 2020$78.38 (-6.42%)Earnings
- DexCom Inc at Cowen HealthCare Conference TranscriptMar 02, 2020
- Q4 2019 DexCom Inc Earnings Call TranscriptFeb 13, 2020$63.05 (+2.52%)Earnings
- DexCom Inc at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- DexCom Inc at Piper Jaffray Healthcare Conference TranscriptDec 04, 2019
- DexCom Inc at Stephens Investor Conference TranscriptNov 13, 2019
- Q3 2019 DexCom Inc Earnings Call TranscriptNov 06, 2019$38.28 (-0.29%)Earnings
- DexCom Inc at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- DexCom Inc at Canaccord Genuity Growth Conference TranscriptAug 07, 2019
- Q2 2019 DexCom Inc Earnings Call TranscriptJul 31, 2019$39.22 (+0.31%)Earnings
- DexCom Inc at William Blair Growth Stock Conference TranscriptJun 05, 2019
- Q1 2019 DexCom Inc Earnings Call TranscriptMay 01, 2019$29.66 (-2.02%)Earnings
- DexCom Inc at Raymond James Institutional Investors Conference TranscriptMar 04, 2019
- Q4 2018 DexCom Inc Earnings Call TranscriptFeb 21, 2019$36.56 (+0.49%)Earnings
Dexcom Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 13, 2021 / 06:00PM GMT
Release Date Price:
$135.11
(-1.63%)
Cecilia E. Furlong
Morgan Stanley, Research Division - Equity Analyst
Good afternoon and thank you for joining us for the third day of the 2021 Morgan Stanley Healthcare Conference. I'm Cecilia Furlong, medical device analyst and a member of the healthcare research team here at Morgan Stanley. It's my pleasure to have DexCom Chairman, President and CEO, Kevin Sayer, with us today.
And quickly, before we begin, I'll run through our disclaimer. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
And with that, Kevin, thank you for joining us today.
Kevin Ronald Sayer
DexCom, Inc. - Executive Chairman, CEO & President
Well, thank you for having me. It's a pleasure to be here.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)